Literature DB >> 26718592

Epidemiology of stroke and transient ischemic attacks: Current knowledge and perspectives.

Y Béjot1, B Daubail2, M Giroud2.   

Abstract

Because of the growing size and aging of the world's population, the global burden of stroke is increasing dramatically. Current epidemiological data indicate that 16.9 million people suffer a stroke each year, which represents a global incidence of 258/100,000/year, with marked differences between high- and low-income countries, and an age-adjusted incidence 1.5 times higher in men than in women. Although primary prevention has contributed to a decrease in stroke incidence in high-income countries, the so-called 'epidemiological transition' has led to an increase in incidence in middle-to-low-income countries as well. In addition, the incidence of ischemic stroke in young adults is on the rise, suggesting a need for specific preventative interventions in that age group. The number of stroke survivors almost doubled between 1990 and 2010, and has now reached 33 million people. According to epidemiological projections, this number will rise to 77 million by 2030. In France, the number of hospitalizations for an acute cerebrovascular event was about 138,000 in 2009, accounting for 3% of the total national health expenditure. Outcomes after stroke are frequently impaired by complications, including motor handicaps, dementia, depression, fatigue, and a high risk of early rehospitalization and institutionalization, with adverse consequences in terms of socioeconomic costs. In addition, there are 5.9 million stroke-related deaths worldwide every year. Finally, although many analytical epidemiological studies have considerably increased our knowledge of risk factors for stroke, the recent INTERSTROKE study provided evidence that 10 risk factors alone accounted for 88% of all strokes. Many of these risk factors are modifiable, which suggests that efforts should be made to promote interventions that aim to reduce the risk of stroke. A new 'mass approach' aiming to reduce the level of stroke risk factors in all people in a region, regardless of any given individual's level of risk, is currently still being developed. This interesting and innovative way to spread stroke awareness is based on the use of an internationally validated mobile-phone application that can calculate the risk of stroke for any given individual, and also contains a section to educate people on stroke warning symptoms and signs.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Epidemiology; Incidence; Mortality; Prevalence; Risk factors; Stroke; Transient ischemic attack

Mesh:

Year:  2015        PMID: 26718592     DOI: 10.1016/j.neurol.2015.07.013

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  51 in total

1.  Virtual reality for the assessment and rehabilitation of neglect: where are we now? A 6-year review update.

Authors:  S Cavedoni; P Cipresso; V Mancuso; F Bruni; E Pedroli
Journal:  Virtual Real       Date:  2022-05-30       Impact factor: 4.697

2.  Ischemic Brain Neurodegeneration.

Authors:  Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

Review 3.  Neuropsychiatric sequelae of stroke.

Authors:  José M Ferro; Lara Caeiro; Maria Luísa Figueira
Journal:  Nat Rev Neurol       Date:  2016-04-11       Impact factor: 42.937

4.  Survivors of Chronic Stroke Experience Continued Impairment of Dexterity But Not Strength in the Nonparetic Upper Limb.

Authors:  Alexander J Barry; Kristen M Triandafilou; Mary Ellen Stoykov; Naveen Bansal; Elliot J Roth; Derek G Kamper
Journal:  Arch Phys Med Rehabil       Date:  2020-02-28       Impact factor: 3.966

5.  Associations of TF Gene Polymorphisms with the Risk of Ischemic Stroke.

Authors:  Yi Cai; Shaofang Wu; Chaosheng Zeng; Qingjie Su; Jingxia Zhou; Pengxiang Li; Mingming Dai; Desheng Wang; Faqing Long
Journal:  J Mol Neurosci       Date:  2018-06-23       Impact factor: 3.444

6.  Acteoside Presents Protective Effects on Cerebral Ischemia/reperfusion Injury Through Targeting CCL2, CXCL10, and ICAM1.

Authors:  Weijiang Wu; Gang Wu; Deyan Cao
Journal:  Cell Biochem Biophys       Date:  2021-01-13       Impact factor: 2.194

Review 7.  Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both?

Authors:  Ryszard Pluta; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 8.  Effectiveness of Combined Thrombolysis and Mild Hypothermia Therapy in Acute Cerebral Infarction: A Meta-Analysis.

Authors:  Lin Guo; Huaien Bu; Maojuan Guo; Yue Zhang; Qun Yu; Bin Yu; Xijuan Jiang; Lin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-16       Impact factor: 2.650

9.  Self-Management in Stroke Survivors: Development and Implementation of the Look after Yourself (LAY) Intervention.

Authors:  Stefania Fugazzaro; Monica Denti; Monia Allisen Accogli; Stefania Costi; Donatella Pagliacci; Simona Calugi; Enrica Cavalli; Mariangela Taricco; Roberta Bardelli
Journal:  Int J Environ Res Public Health       Date:  2021-05-31       Impact factor: 3.390

10.  A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study.

Authors:  Erin Godecke; Elizabeth Armstrong; Tapan Rai; Natalie Ciccone; Miranda L Rose; Sandy Middleton; Anne Whitworth; Audrey Holland; Fiona Ellery; Graeme J Hankey; Dominique A Cadilhac; Julie Bernhardt
Journal:  Int J Stroke       Date:  2020-10-06       Impact factor: 5.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.